BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mi L, Zhang K, Ma JX, Yao JF, Tong YL, Bao ZJ. Hollow cerium nanoparticles synthesized by one-step method for multienzyme activity to reduce colitis in mice. World J Gastroenterol 2025; 31(5): 98732 [PMID: 39926211 DOI: 10.3748/wjg.v31.i5.98732]
URL: https://www.wjgnet.com/1007-9327/full/v31/i5/98732.htm
Number Citing Articles
1
Tianlin Wang, Xiaoxia Lin, Wenjie Li, Xing Li, Xiaodong Lin, Ning Li, Yan Ma, Lianjun Song, Xianqing Huang, Tiange Li. Resveratrol-embedded hollow cerium oxide nanomedicine targeted treat inflammatory bowel disease through ROS clearance, intestinal mucosal immune homeostasis recovery and gut microbiota modulationMaterials Today Bio 2026; 36: 102765 doi: 10.1016/j.mtbio.2026.102765
2
Tingting Hu, Xiaoting Zhang, Mengmeng Dong, Fei Kong, Zhen Wang, Kaiqiang Li, Yu Cai, Xiangmin Tong, Ke Hao. Nanozymes in IBD therapy: Rational design, catalytic mechanisms and targeted therapies deliveryMaterials & Design 2026; 262: 115475 doi: 10.1016/j.matdes.2026.115475
3
Misagh Yahya, Javad Safaei-Ghomi, Abdolrasoul Haghir-Ebrahimabadi, Hanieh Jalali, Hossein Mojtabazadeh. Design and biological evaluation of mesalamine–NSAID hybrids targeting the NLRP3 inflammasome: a multi-target strategy for ulcerative colitis therapyScientific Reports 2025; 16(1) doi: 10.1038/s41598-025-31910-5